Implicit Bias From Providers Inhibits HCV Treatment
A new study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with HIV and HCV has been increasing. If left untreated, HCV infection can lead to liver damage, cancer, and death. Although HIV requires lifelong therapy, HCV can be cured with a few months of oral medications.
New Tools Enable Non-Clinicians to Diagnose Substance Use Disorders
A new study by Yale School of Medicine (YSM) and NYU Grossman School of Medicine researchers demonstrates the validity of two new diagnostic tools—the Rapid Opioid Use Disorder Assessment and the Rapid Stimulant Use Disorder Assessment. These instruments may be used to increase diagnoses of opioid and stimulant use disorder and access to treatment.
Murray Named Interim Section Chief of Pediatric Infectious Diseases at Yale School of Medicine and Yale New Haven Children’s Hospital
Thomas Murray, MD, PhD, professor of pediatrics (infectious disease), has been named Interim Section Chief of Pediatric Infectious Diseases at Yale School of Medicine and Yale New Haven Children’s Hospital effective September 1, 2023.
YSM Faculty Developing “Game Changer” for Global Health
Dengue. Zika. Lyme. Yellow fever. Chikungunya virus. Malaria. These worldwide diseases, and others, are spread by the bite from an infected arthropod, a tick or mosquito. Five faculty from Yale School of Medicine (YSM) are collaborating on a project focusing on creating vaccines against infectious diseases by targeting the vector, which could be a “game changer” for global health.
Initiative Tackles Diversity, Equity, and Anti-racism Within Infectious Diseases
As the summer season of 2020 peaked, amidst a swelling pandemic and the murder of George Floyd, a team of physicians and staff within the Yale Department of Internal Medicine’s Section of Infectious Diseases banded together with university historians and experts from the Poorvu Center for Teaching and Learning to create a space to address diversity, equity, and anti-racism. Initially spearheaded by Lydia Aoun-Barakat, MD, associate professor of medicine (infectious diseases), and Gerald Friedland, MD, professor emeritus (infectious diseases), the section established the Infectious Diseases Diversity, Equity, and Antiracism (ID2EA) consortium, which aims to address systemic racism, promote diversity, and promote equity within the infectious disease space both at Yale and beyond via interactive learning sessions.
Yale Study Offers Multiple Strategies for Containing Monkeypox
A new study from the Yale School of Public Health (YSPH) sets specific targets for containment and offers multiple strategies for limiting the spread of monkeypox using basic public-health tools of community detection, contact tracing, and vaccination.
CT’s coronavirus transmission rate tops important threshold
The coronavirus transmission rate in Connecticut has risen slightly above one, meaning that COVID-19 may have started to spread again in the state, albeit slowly, even as new case numbers remain low. “If that is greater than one, the number of cases is going to grow,” Virginia Pitzer, an associate professor of the epidemiology of microbial disease at the Yale School of Public Health, explained about the transmission rate.Source: CT Post
Connecticut Claims Lowest Rate Of COVID Transmission In The Country
Data shows Connecticut is succeeding in slowing the spread of COVID-19, even as cases of the virus spike in other states. Governor Ned Lamont tweeted data this week that shows the state with the lowest COVID-19 growth rate in the country by far.Source: WSHU public radio
Spike In Coronavirus Cases Overwhelms Testing Labs Across The U.S.
ALISON GALVANI: You will have missed your window of opportunity to curtail their transmission. It makes it much more challenging to control the disease. It's a gap that we need to close in order to bring this disease under control.Source: NPR
Sports bubbles are good places to study COVID-19
Sports are coming back in the United States, and as they do, professional leagues are creating conditions that researchers say are tailor-made to study COVID-19. They offer sizable groups of people who are regularly monitored by doctors. When leagues enter a pandemic isolation zone, like the National Basketball Association plans to at Disney World, the controlled environment offers even more opportunities to understand the virus.Source: The Verge
Dominant Coronavirus Strain Appears to Be a Mutated, More Virulent Version, Study Finds
The genetic variation of the novel coronavirus that dominates the world today infects human cells more readily than the original that emerged in China, according to a new study published in the journal Cell on Thursday.Source: Science alert